Table 2 Univariate analysis for cancer-specific survival (log rank P-value)
Variables | Cases (n) | 5-year cancer-specific survival (%) | Log rank P-value |
|---|---|---|---|
Age (years) | 0:13 | ||
≤60 | 30 | 84.60 | |
>60 | 43 | 73.90 | |
Gender | 0:37 | ||
Male | 55 | 80.20 | |
Female | 18 | 74.40 | |
Mode of presentation | 0.69 | ||
Incidental | 35 | 76.10 | |
Symptomatic | 38 | 70.50 | |
Size (cm) | 0:31 | ||
≤5.5 | 36 | 89.30 | |
>5.5 | 37 | 68.80 | |
PT (2002) | 0.0005 | ||
pT1 and pT2 | 45 | 91.40 | |
pT3 and pT4 | 28 | 56 | |
N (2002) | 0.008 | ||
N0 | 68 | 81.80 | |
N+ | 5 | 40 | |
M | <0.0001 | ||
M0 | 66 | 88.30 | |
M+ | 7 | 0 | |
Grading | 0.050694444 | ||
Grades 1 and 2 | 27 | 82.70 | |
Grades 3 and 4 | 46 | 77.20 | |
Necrosis | 0:06 | ||
Absent | 61 | 81.40 | |
Present | 12 | 66.60 | |
SSIGN score | <0.0001 | ||
0–2 | 21 | 100 | |
3–4 | 24 | 93.3 | |
5–6 | 13 | 66.6 | |
7–9 | 12 | 37.5 | |
≥10 | 3 | 0 | |
Loss of chromosome 9p | 0.0003 | ||
Absent | 61 | 87.90 | |
Present | 12 | 43.20 |
